The Latest
-
5 things to watch on the ASX 200 on Tuesday
-
Is Immunomedics, Inc. (IMMU) Going to Burn These Hedge Funds?
-
Why Facebook (FB) is Expected to Grow Sales at a Stellar Rate
-
Sarepta Gene Therapy Win Helps to Validate Broader Platform